DPOGS212091 | ||
---|---|---|
Transcript | DPOGS212091-TA | 630 bp |
Protein | DPOGS212091-PA | 209 aa |
Genomic position | DPSCF300038 - 983168-1003288 | |
RNAseq coverage | 779x (Rank: top 17%) |
Annotation | ||||
---|---|---|---|---|
Heliconius | HMEL012555 | 5e-63 | 94.31% |   |
Bombyx | BGIBMGA006725-TA | 2e-90 | 96.30% |   |
Drosophila | rl-PF | 1e-102 | 88.60% |   |
EBI UniRef50 | UniRef50_P40417 | 2e-100 | 88.60% | Mitogen-activated protein kinase ERK-A n=46 Tax=Bilateria RepID=ERKA_DROME |
NCBI RefSeq | NP_001036921.1 | 3e-114 | 95.12% | extracellular regulated MAP kinase [Bombyx mori] |
NCBI nr blastp | gi|112982894 | 6e-113 | 95.12% | extracellular regulated MAP kinase [Bombyx mori] |
NCBI nr blastx | gi|112982894 | 3e-109 | 95.12% | extracellular regulated MAP kinase [Bombyx mori] |
Group | ||||
---|---|---|---|---|
Gene Ontology | GO:0016772 | 3.8e-55 | transferase activity, transferring phosphorus-containing groups | |
GO:0005524 | 7.2e-48 | ATP binding | ||
GO:0004672 | 7.2e-48 | protein kinase activity | ||
GO:0006468 | 7.2e-48 | protein phosphorylation | ||
GO:0004674 | 7.6e-25 | protein serine/threonine kinase activity | ||
GO:0004707 | 1.5e-16 | MAP kinase activity | ||
GO:0004713 | 5.3e-08 | protein tyrosine kinase activity | ||
KEGG pathway | tca:655225 | 3e-108 |   | |
  | K04371 (ERK1_2) | maps-> | Regulation of actin cytoskeleton | |
  |   |   | Fc epsilon RI signaling pathway | |
  |   |   | Toll-like receptor signaling pathway | |
  |   |   | Gap junction | |
  |   |   | Melanoma | |
  |   |   | Pathways in cancer | |
  |   |   | Chemokine signaling pathway | |
  |   |   | Endometrial cancer | |
  |   |   | Natural killer cell mediated cytotoxicity | |
  |   |   | Neurotrophin signaling pathway | |
  |   |   | T cell receptor signaling pathway | |
  |   |   | Long-term depression | |
  |   |   | Melanogenesis | |
  |   |   | ErbB signaling pathway | |
  |   |   | Colorectal cancer | |
  |   |   | GnRH signaling pathway | |
  |   |   | Aldosterone-regulated sodium reabsorption | |
  |   |   | Adherens junction | |
  |   |   | Type II diabetes mellitus | |
  |   |   | Long-term potentiation | |
  |   |   | Renal cell carcinoma | |
  |   |   | Pancreatic cancer | |
  |   |   | Acute myeloid leukemia | |
  |   |   | Vascular smooth muscle contraction | |
  |   |   | Non-small cell lung cancer | |
  |   |   | Chronic myeloid leukemia | |
  |   |   | Axon guidance | |
  |   |   | Prostate cancer | |
  |   |   | Leishmaniasis | |
  |   |   | MAPK signaling pathway | |
  |   |   | Alzheimer's disease | |
  |   |   | Fc gamma R-mediated phagocytosis | |
  |   |   | Dorso-ventral axis formation | |
  |   |   | Glioma | |
  |   |   | B cell receptor signaling pathway | |
  |   |   | Shigellosis | |
  |   |   | Chagas disease | |
  |   |   | TGF-beta signaling pathway | |
  |   |   | Insulin signaling pathway | |
  |   |   | Focal adhesion | |
  |   |   | Oocyte meiosis | |
  |   |   | MAPK signaling pathway - fly | |
  |   |   | Thyroid cancer | |
  |   |   | mTOR signaling pathway | |
  |   |   | Progesterone-mediated oocyte maturation | |
  |   |   | Bladder cancer | |
  |   |   | Prion diseases | |
  |   |   | NOD-like receptor signaling pathway | |
  |   |   | VEGF signaling pathway | |
InterPro domain | [14-203] IPR011009 | 3.8e-55 | Protein kinase-like domain | |
[28-203] IPR017442 | 7.2e-48 | Serine/threonine-protein kinase-like domain | ||
[28-209] IPR002290 | 7.6e-25 | Serine/threonine-protein kinase domain | ||
[16-33] IPR008349 | 1.5e-16 | ERK1/2 MAP kinase | ||
[28-209] IPR020635 | 5.3e-08 | Tyrosine-protein kinase, catalytic domain | ||
Orthology group | MCL14610 |   | Patchy |
Genotypes for resequenced monarchs and outgroup Danaus species |
---|
>DPOGS212091-TA
ATGGCCGAGGCTGCAGCTGCTGCTAGCACTAATCCCAATGCGGAGATTGTGCGGGGTCAGGTGTTCGAAGTTGGGCCTAGATACAAGAGCTTGCAGTACATTGGGGAAGGAGCCTATGGCATGGTTGTGTCCGCCTACGACACCATGAAGCTAGCTAAAGTCGCCATTAAGAAAATATCACCTTTCGAACACCAGACTTACTGTCAGAGGACGCTTAGGGAAATCAAGATTCTGACACGATTTAAGCATGAGAATATAATTGATATTAGAGATATTTTAAGAGCCGAAACAATCGATCAAATGAAGGACGTCTACATCGTCCAGTGTTTGATGGAGACGGATCTTTATAAGTTATTAAAAACACAAAAATTAAGTAACGATCACATCTGCTACTTCCTGTATCAAATCCTGCGAGGTTTGAAGTACATACACTCGGCCAACGTGCTCCACCGCGACCTCAAACCGTCTAACCTGCTCCTCAACACCACCTGTGACCTAAAGATATGTGACTTTGGTCTGGCTCGCGTGGCCGACCCTGATCATGACCACACAGGCTTCCTCACGGAGTACGTCGCAACACGCTGGTATCGTGCACCAGAGATCATGCTGATGAGCTTCCATAACATATAG
>DPOGS212091-PA
MAEAAAAASTNPNAEIVRGQVFEVGPRYKSLQYIGEGAYGMVVSAYDTMKLAKVAIKKISPFEHQTYCQRTLREIKILTRFKHENIIDIRDILRAETIDQMKDVYIVQCLMETDLYKLLKTQKLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLMSFHNI-